IFNB1 and myeloid sarcoma: mDCs freshly isolated from IFNb-treated patients showed significant greater expression of the transcription factor STAT1 mRNA (p < 0.01) and a trend to increased STAT3 as compared to mDCs from HCs and UnRx’d MS patients.